Use of sirolimus-eluting stents for treatment of in-stent restenosis: Long-term follow-up

Journal of Cardiovascular Medicine

Volumn 8, Issue 9, 2007, Pages 699-705

  Brambilla, Nedy ^a   Ferrario, Maurizio ^a   Repetto, Alessandra ^a   Bramucci, Ezio ^a   Angoli, Luigi ^a   Canosi, Umberto ^a   Rosso, Roberta ^a   Ferlini, Marco ^a   Klersy, Catherine ^a   Tavazzi, Luigi ^a  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

In stent restenosis; Revascularisation; Sirolimus eluting stents

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HEPARIN; RAPAMYCIN; TICLOPIDINE;

ADULT; AGED; ARTICLE; CORONARY ARTERY; CORONARY STENT; DIABETIC PATIENT; FEMALE; FOLLOW UP; HEART MUSCLE ISCHEMIA; HOSPITALIZATION; HUMAN; HYPERTENSION; IMPLANTATION; INCIDENCE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; RECURRENCE RISK; RESTENOSIS; RISK FACTOR;

CORONARY RESTENOSIS; DRUG DELIVERY SYSTEMS; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HEART DISEASES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; RISK FACTORS; SIROLIMUS; STENTS; TREATMENT OUTCOME;

EID: 34548051116     PISSN: 15582027     EISSN: None     Source Type: Journal    
DOI: 10.2459/JCM.0b013e328010395d     Document Type: Article

References (50)

1. Mehran R, Dangas G, Abizaid AS, Mintz GS, Lansky AJ, Satler LF, et al. Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Circulation 1999; 100:1872-1878.
2. Lowe HC, Oesterle SN, Khachigian LM. Coronary in-stent restenosis: current status and future strategies. J Am Coll Cardiol 2002; 39:183-193.
3. Eltchaninoff H, Koning R, Tron C, Gupta V, Cribier A. Balloon angioplasty for the treatment of coronary in-stent restenosis: immediate results and 6-month angiographic recurrent restenosis rate. J Am Coll Cardiol 1998; 32:980-984.
4. Bossi I, Klersy C, Black AJ, Cortina R, Choussat R, Cassagneau B, et al. In-stent restenosis: long-term outcome and predictors of subsequent target lesion revascularization after repeat balloon angioplasty. J Am Coll Cardiol 2000; 35:1569-1576.
5. Alfonso F, Zueco J, Cequier A, Mantilla R, Bethencourt A, Lopez-Minguez JR, et al., for the Restenosis Intra-Stent: Balloon Angioplasty Versus Elective Stenting (RIBS) Investigators. A randomized comparison of repeat stenting with balloon angioplasty in patients with in-stent restenosis. J Am Coll Cardiol 2003; 42:796-805.
6. Mehran R, Mintz GS, Satler LF, Pichard AD, Kent KM, Bucher TA, et al. Treatment of in-stent restenosis with excimer laser coronary angioplasty: mechanisms and results compared with PTCA alone. Circulation 1997; 96:2183-2189.
7. Vom Dahl J, Dietz U, Haager PK, Silber S, Niccoli L, Buettner HJ, et al. Rotational atherectomy does not reduce recurrent in-stent restenosis: results of angioplasty versus rotational atherectomy for treatment of diffuse in-stent restenosis trial (ARTIST). Circulation 2002; 105:583-588.
8. Sharma SK, Kini A, Mehran R, Lansky A, Kobayashi Y, Marmur JD. Randomized trial of Rotational Atherectomy Versus Balloon Angioplasty for Diffuse In-Stent Restenosis (ROSTER). Am Heart J 2004; 147:16-22.
9. Airoldi F, Di Mario C, Stankovic G, Briguori C, Bramucci E, Reimers B, et al. Effectiveness of treatment of in-stent restenosis with an 8-French compatible atherectomy catheter. Am J Cardiol 2003; 92:725-728.
10. Albiero R, Silber S, Di Mario C, Cernigliaro C, Battaglia S, Reimers B, et al., for the RESCUT Investigators. Cutting balloon versus conventional balloon angioplasty for the treatment of in-stent restenosis: results of the restenosis cutting balloon evaluation trial (RESCUT). J Am Coll Cardiol 2004; 43:943-949.
11. Waksman R, Raizner AE, Yeung AC, Lansky AJ, Vandertie L. Use of localised intracoronary beta radiation in treatment of in-stent restenosis: the INHIBIT randomised controlled trial. Lancet 2002; 359:551-557.
12. Popma JJ, Suntharalingam M, Lansky AJ, Heuser RR, Speiser B, Teirstein PS, et al., for the Stents and Radiation Therapy (START) Investigators. Randomized trial of 90Sr/90Y beta-radiation versus placebo control for treatment of in-stent restenosis. Circulation 2002; 106:1090-1096.
13. Waksman R, Cheneau E, Ajani AE, White RL, Pinnow E, Torguson R, et al. Intracoronary radiation therapy improves the clinical and angiographic outcomes of diffuse in-stent restenotic lesions: results of the Washington Radiation for In-Stent Restenosis Trial for Long Lesions (Long WRIST) Studies. Circulation 2003; 107:1744-1749.
14. Waksman R, White RL, Chan RC, Bass BG, Geirlach L, Mintz GS, et al. Intracoronary gamma-radiation therapy after angioplasty inhibits recurrence in patients with in-stent restenosis. Circulation 2000; 101:2165-2171.
15. Teirstein PS, Massullo V, Jani S, Popma JJ, Russo RJ, Schatz RA, et al. Three-year clinical and angiographic follow-up after intracoronary radiation: results of a randomized clinical trial. Circulation 2000; 101:360-365.
16. Leon MB, Teirstein PS, Moses JW, Tripuraneni P, Lansky AJ, Jani S, et al. Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting. N Engl J Med 2001; 344:250-256.
17. Urban P, Serruys P, Baumgart D, Colombo A, Silber S, Eeckhout E, et al., for the RENO Investigators. A multicentre European registry of intraluminal coronary beta brachytherapy. Eur Heart J 2003; 24:604-612.
18. Albiero R, Nishida T, Adamian M, Amato A, Vaghetti M, Corvaja N, et al. Edge restenosis after implantation of high activity 32P radioactive beta-emitting stents. Circulation 2000; 101:2454-2457.
19. Sabate M, Costa MA, Kozuma K, Kay IP, van der Giessen WJ, Coen VL, et al. Geographic miss: a cause of treatment failure in radio-oncology applied to intracoronary radiation therapy. Circulation 2000; 101:2467-2471.
20. Costa MA, Sabate M, van der Giessen WJ, Kay IP, Cervinka P, Ligthart JM, et al. Late coronary occlusion after intracoronary brachytherapy. Circulation 1999; 100:789-792.
21. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, et al., for the RAVEL Study Group. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002; 346:1773-1780.
22. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, et al., for the SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003; 349:1315-1323.
23. Schofer J, Schluter M, Gershlick AH, Wijns W, Garcia E, Schampaert E, et al., for the E-SIRIUS Investigators. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS). Lancet 2003; 362:1093-1099.
24. Schampaert E, Cohen EA, Schluter M, Reeves F, Traboulsi M, Title LM, et al., for the C-SIRIUS Investigators. The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS). J Am Coll Cardiol 2004; 43:1110-1115.
25. Sousa JE, Costa MA, Abizaid A, Sousa AG, Feres F, Mattos LA, et al. Sirolimus-eluting stent for the treatment of in-stent restenosis: a quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation 2003; 107:24-27.
26. Degertekin M, Regar E, Tanabe K, Smits PC, van der Giessen WJ, Carlier SG, et al. Sirolimus-eluting stent for treatment of complex in-stent restenosis: the first clinical experience. J Am Coll Cardiol 2003; 41:184-189.
27. Saia F, Lemos PA, Arampatzis CA, Hoye A, Degertekin M, Tanabe K, et al. Routine sirolimus eluting stent implantation for unselected in-stent restenosis: insights from the rapamycin eluting stent evaluated at Rotterdam Cardiology Hospital (RESEARCH) registry. Heart 2004; 90:1183-1188.
28. Kastrati A, Mehilli J, von Beckerath N, Dibra A, Hausleiter J, Pache J, et al., for the ISAR-DESIRE Study Investigators. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial. JAMA 2005; 293:165-171.
29. Iofina E, Haager PK, Radke PW, Langenberg R, Blindt R, Ortlepp J, et al. Sirolimus- and paclitaxel-eluting stents in comparison with balloon angioplasty for treatment of in-stent restenosis. Catheter Cardiovasc Interv 2005; 64:28-34.
30. Neumann FJ, Desmet W, Grube E, Brachmann J, Presbitero P, Rubartelli P, et al. Effectiveness and safety of sirolimus-eluting stents in the treatment of restenosis after coronary stent placement. Circulation 2005; 111:2107-2111.
31. Alfonso F, Perez-Vizcayno MJ, Hernandez R, Bethencourt A, Marti V, Lopez-Minguez JR, et al., for the RIBS-II Investigators. A randomized comparison of sirolimus-eluting stent with balloon angioplasty in patients with in-stent restenosis: results of the Restenosis Intrastent: Balloon Angioplasty Versus Elective Sirolimus-Eluting Stenting (RIBS-II) trial. J Am Coll Cardiol 2006; 47:2152-2160.
32. Holmes DR Jr, Teirstein P, Satler L, Sketch M, O'Malley J, Popma JJ, et al., for the SISR Investigators. Sirolimus-eluting stent vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the SISR randomized trial. JAMA 2006; 295:1264-1273.
33. Mancini GB, Simon SB, McGillem MJ, LeFee MT, Friedman HZ, Vogel RA. Automated quantitative coronary arteriography: morphologic and physiologic validation in vivo of a rapid digital angiographic method. Circulation 1987; 75:452-460.
34. Teirstein PS, Massullo V, Jani S, Popma JJ, Mintz GS, Russo RJ, et al. Catheter-based radiotherapy to inhibit restenosis after coronary stenting. N Engl J Med 1997; 336:1697-1703.
35. Adamian M, Colombo A, Briguori C, Nishida T, Marsico F, Di Mario C, et al. Cutting balloon angioplasty for the treatment of in-stent restenosis: a matched comparison with rotational atherectomy, additional stent implantation and balloon angioplasty. J Am Coll Cardiol 2001; 38:672-679.
36. Elezi S, Kastrati A, Hadamitzky M, Dirschinger J, Neumann FJ, Schomig A. Clinical and angiographic follow-up after balloon angioplasty with provisional stenting for coronary in-stent restenosis. Catheter Cardiovasc Interv 1999; 48:151-156.
37. Bossi I, Klersy C, Black AJ, Cortina R, Choussat R, Cassagneau B, et al. In-stent restenosis: long-termoutcome and predictors of subsequent target lesion revascularization after repeat balloon angioplasty. J Am Coll Cardiol 2000; 35:1569-1576.
38. Kastrati A, Schomig A, Elezi S, Schuhlen H, Dirschinger J, Hadamitzky M, et al. Predictive factors of restenosis after coronary stent placement. J Am Coll Cardiol 1997; 30:1428-1436.
39. Goldberg SL, Loussararian A, De Gregorio J, Di Mario C, Albiero R, Colombo A. Predictors of diffuse and aggressive intra-stent restenosis. J Am Coll Cardiol 2001; 37:1019-1025.
40. Mercado N, Boersma E, Wijns W, Gersh BJ, Morillo CA, de Valk V, et al. Clinical and quantitative coronary angiographic predictors of coronary restenosis: a comparative analysis from the balloon-to-stent era. J Am Coll Cardiol 2001; 38:645-652.
41. Colombo A, Orlic D, Stankovic G, Corvaja N, Spanos V, Montorfano M, et al. Preliminary observations regarding angiographic pattern of restenosis after rapamycin-eluting stent implantation. Circulation 2003; 107:2178-2180.
42. Fujii K, Mintz GS, Kobayashi Y, Carlier SG, Takebayashi H, Yasuda T, et al. Contribution of stent underexpansion to recurrence after sirolimus-eluting stent implantation for in-stent restenosis. Circulation 2004; 109:1085-1088.
43. Saia F, Lemos PA, Sianos G, Degertekin M, Lee CH, Arampatzis CA, et al. Effectiveness of sirolimus-eluting stent implantation for recurrent in-stent restenosis after brachytherapy. Am J Cardiol 2003; 92:200-203.
44. Iakovou I, Sangiorgi GM, Stankovic G, Corvaja N, Michev I, Chieffo A, et al. Effectiveness of sirolimus-eluting stent implantation for treatment of in-stent restenosis after brachytherapy failure. Am J Cardiol 2004; 94:351-354.
45. Schiele TM, Rieber J, Konig A, Leibig M, Erhard I, Theisen K, et al. Comparison of acute and long-term results and underlying mechanisms from sirolimus-eluting stent implantation for the treatment of in-stent restenosis and recurrent in-stent restenosis in patients in whom intracoronary radiation failed as assessed by intravascular ultrasound. Am J Cardiol 2004; 94:917-921.
46. Lemos PA, Hoye A, Goedhart D, Arampatzis CA, Saia F, van der Giessen J, et al. Clinical, angiographic, and procedural predictors of angiographic restenosis after sirolimus-eluting stent implantation in complex patients: an evaluation from the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) study. Circulation 2004; 109:1366-1370.
47. Saia F, Lemos PA, Hoye A, Sianos G, Arampatzis CA, de Feyter PJ, et al. Clinical outcomes for sirolimus-eluting stent implantation and vascular brachytherapy for the treatment of in-stent restenosis. Catheter Cardiovasc Interv 2004; 62:283-288.
48. Iofina E, Radke PW, Skurzewski P, Haager PK, Blindt R, Koch KC, et al. Superiority of sirolimus eluting stent compared with intracoronary beta radiation for treatment of in-stent restenosis: a matched comparison. Heart 2005; 91:1584-1589.
49. Stone GW, Ellis SG, O'Shaughnessy CD, Martin SL, Satler L, McGarry T, et al., for the TAXUS V ISR Investigators. Paclitaxel-eluting stents vs brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial. JAMA 2006; 295:1253-1263.
50. Silber S, Albertsson P, Aviles FF, Camici PG, Colombo A, Hamm C, et al. Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J 2005; 26:804-847.